SBIO241220C38000
- 1.05
- 0.000.00%
Alps Etf Trust Medical Breakthroughs Etf Newsroom
Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs
Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025
Trump Media Saw the Largest Increase in Short Interest in October
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Hedge Funds Were Net Buyers of Financials, Healthcare for Week: Goldman Sachs
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
Druckenmiller made significant adjustments in the third quarter: opened positions in Bank of America and Broadcom, continued to increase holdings in the top position Natera.
Natera's position significantly increased by 80.61% compared to the previous quarter. Druckenmiller also established new positions in Broadcom, banks, and pharmaceutical stocks, while completely liquidating News Corp and telecom company Liberty Global, and reducing shareholding in microsoft.
Druckenmiller's Duquesne Closes Some Media Holdings, Loads Into Regional Banks, Among Q3 Trades
Avidity Biosciences Jumps 16%; Reaches All-time High
Alkermes Analyst Ratings
Avidity Biosciences Analyst Ratings
Crinetics Expects That Its Cash & Equivalents To Be Sufficient To Fund Its Current Operating Plan Into 2029
Crinetics Pharmaceuticals Q3 2024 GAAP EPS $(0.96) Misses $(0.92) Estimate
Chevron, Super Micro Computer Top List of Most Shorted Large-cap Stocks in October, Hazeltree Says
Argenx Upgraded at Wolfe on Myasthenia Gravis Dominance
JFrog Slips as Earnings Season Hops Along While Pair of Semis Rebound
Piper Sandler Maintains Overweight on Arcellx, Raises Price Target to $115
PTC Therapeutics Analyst Ratings
Avidity Biosciences Q3 EPS $(0.65) Beats $(0.73) Estimate, Sales $2.34M Miss $4.27M Estimate
PTC Therapeutics GAAP EPS of -$1.39 Beats by $0.13, Revenue of $196.78M Beats by $24.98M